Literature DB >> 7508274

The structural barrier of absorptive mucosae: site difference of the permeability of fluorescein isothiocyanate-labelled dextran in rabbits.

K Hosoya1, H Kubo, H Natsume, K Sugibayashi, Y Morimoto, S Yamashita.   

Abstract

The permeability of fluorescein isothiocyanate-labelled dextran (FD, M.W. 4400-71,200) across nasal, buccal, duodenal, jejunal, ileal, colonic, and rectal mucosae excised from rabbits has been measured to estimate the structural barrier of absorptive mucosae using Ussing-type diffusion chambers. The permeability coefficient of FD in all these mucosae decreased with increasing molecular weight. The rank order of FD permeability did not always correlate with the electrical resistance of the mucosae. Among components of the small intestine (duodenum, jejunum, ileum) and the large intestine (colon, rectum), however, the rank order of FD permeability corresponded to the magnitude of the electrical resistance in each instance; the upper colonic mucosa showed the highest permeability, especially in FD of low molecular weight, and permeability of the rectal mucosa was lowest except for the duodenal mucosa. The nasal mucosa showed the lowest electrical resistance and the highest permeability of those studied, suggesting that it has a leaky structural barrier.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7508274     DOI: 10.1002/bdd.2510140805

Source DB:  PubMed          Journal:  Biopharm Drug Dispos        ISSN: 0142-2782            Impact factor:   1.627


  6 in total

1.  The characterization of the human nasal epithelial cell line RPMI 2650 under different culture conditions and their optimization for an appropriate in vitro nasal model.

Authors:  Mateja Erdani Kreft; Urška Dragin Jerman; Eva Lasič; Tea Lanišnik Rižner; Neli Hevir-Kene; Luka Peternel; Katja Kristan
Journal:  Pharm Res       Date:  2014-08-22       Impact factor: 4.200

2.  Confocal laser scanning microscopic visualization of the transport of dextrans after nasal administration to rats: effects of absorption enhancers.

Authors:  E Marttin; J C Verhoef; C Cullander; S G Romeijn; J F Nagelkerke; F W Merkus
Journal:  Pharm Res       Date:  1997-05       Impact factor: 4.200

3.  Insoluble powder formulation as an effective nasal drug delivery system.

Authors:  Fusashi Ishikawa; Mika Murano; Minoru Hiraishi; Toshikazu Yamaguchi; Ikumi Tamai; Akira Tsuji
Journal:  Pharm Res       Date:  2002-08       Impact factor: 4.200

4.  Effect of sodium taurodihydrofusidate on nasal drug delivery: differences in its concentration and penetrant molecular weight.

Authors:  K Hosoya; H Kubo; T Akutsu; H Natsume; K Sugibayashi; Y Morimoto
Journal:  Arch Pharm Res       Date:  1994-04       Impact factor: 4.946

5.  Poly-L-arginine predominantly increases the paracellular permeability of hydrophilic macromolecules across rabbit nasal epithelium in vitro.

Authors:  Kazuo Ohtake; Takaya Maeno; Hideo Ueda; Hideshi Natsume; Yasunori Morimoto
Journal:  Pharm Res       Date:  2003-02       Impact factor: 4.200

6.  Improved Intranasal Retentivity and Transnasal Absorption Enhancement by PEGylated Poly-l-ornithine.

Authors:  Yusuke Kamiya; Tsutomu Yamaki; Shigehiro Omori; Masaki Uchida; Kazuo Ohtake; Mitsutoshi Kimura; Hiroshi Yamazaki; Hideshi Natsume
Journal:  Pharmaceuticals (Basel)       Date:  2018-01-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.